Brian R. Stanton, Ph.D.
Brian R. Stanton, Ph.D. works on IP, trade, and associated technology innovation policy matters. A principal in Stanton Consulting Services, Dr. Stanton was the Director of the Division of Policy at the National Institutes of Health’s (NIH) Office of Technology Transfer and was responsible for IP and technology transfer policy for the U.S. Public Health Service (NIH, FDA, and CDC) until 2006. His prior appointment at the US Patent and Trademark Office included efforts in establishing IP standards for bioinformatics, transgenic animals, and genomics.
Posts by Brian R. Stanton, Ph.D.
PTO Report on Confirmatory Genetic Testing: A Worthwhile Effort But Not Far Enough
The USPTO has released its 'Report on Confirmatory Genetic Diagnostic Testing,' which was prepared to fulfill the requirements of §27 of the Leahy-Smith America Invents Act. The …
Can Diagnostics Companies Afford to Provide Ebola Testing?
In a least one instance, a major laboratory test provider has indicated (in confidence) that it would not be entering the Ebola testing market for three principle …
An Ex-insider’s Perspective of the USPTO Special Applications Warning System (SAWS)
This was the SAWS program; an oversight procedure for bringing information to the attention of management. It was designed, by intention, to cast a broad and sweeping …
Deputy for Patent Exam Policy: The Devil is in the Details
We argue, hour by hour, day by day, about large issues of morality and ethics and discuss how to make our nation “green”. We discuss large high-level …
